Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
3.260
+0.082 (2.58%)
At close: May 12, 2025, 4:00 PM
3.320
+0.060 (1.84%)
After-hours: May 12, 2025, 7:55 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $2.95 million as of May 12, 2025. Its market cap has decreased by -13.53% in one year.
Market Cap
2.95M
Enterprise Value
-753.57K
1-Year Change
-13.53%
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.67M to $2.95M, a decrease of -96.75%. That is a compound annual growth rate of -53.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.88M | -25.32% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.48% |
| Dec 30, 2022 | 4.47M | -93.31% |
| Dec 31, 2021 | 66.83M | -28.42% |
| Dec 31, 2020 | 93.37M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |